Founders First 1517 Fund

Hamama is helping people grow nutritious microgreens in their home, year-round. Camille Richman, and her co-founder Dan Goodman, started the company after meeting at MIT.

Their product consists of 3 seed quilts that are laid in a reusable growing tray.

Years of growing food in the lab and at home have made their system fail-proof and a viable option for inexperienced gardeners to benefit from homegrown veggies. Those greens are supremely fresh, extremely nutritious, and a novel addition to most diets.

Camille talks with 1517 Fund’s Zak Slayback about their rigorous customer discovery process, how they’ve built everything themselves, and the potential market with Baby Boomers.

Connect with Camille & Hamama

hamama.com

Connect with 1517 Fund

https://www.1517fund.com/take-action

Next Gen started as an event that barely sold any tickets. Today, the community reaches tens of thousands of entrepreneurs through weekly emails, daily Facebook group activity, and a yearly conference.

Next Gen was started by Dylan Gambardella and Justin Lafazan, who had a vision to provide resources to anyone and everyone in the nascent stages of building something for themselves.

Today, they help leading brands like Target, Capital One, and Dell access, engage with, and influence the next generation.

In this conversation with 1517 Fund’s Zak Slayback, Dylan and Justin explain the early hustle they undertook to launch the first Summit, how they collectively bargain for their community, and their commitment to replying to every question and ask.

Connect with Justin, Dylan, and Next Gen

ngsummit.com

Connect with 1517 Fund

https://www.1517fund.com/take-action

Cameron Graham and the Storii team are building a software platform for Senior Care Facilities. As the CEO, Cameron is responsible for leading their efforts to sell, fundraise and paint a vision for the future.

The Storii product started with enabling care staff to digitally schedule and record the care they provide. It has evolved into a tool for case notes, family messaging, media consumption, and more.

In this episode, you’ll hear Cameron and 1517 Fund’s Zak Slayback talk about how Cameron found his way into senior care, the challenges of being so young in such a conservative industry, and the disciplined customer discovery process Storii has followed.

Connect with Cam & Storii

http://storii.com

Connect with 1517 Fund

https://www.1517fund.com/take-action

Nick Friedman co-founded Board, a disruptive mortgage company, and now serves as Chief Operating Officer. Board’s founding idea is to level the playing field for home buyers by upgrading any offer into an all-cash offer.

Board purchases homes in cash on behalf of approved buyers then sells the home back to the buyer once they’ve gotten their mortgage.

You’ll hear Nick and 1517 Fund’s Zak Slayback discuss how Board narrowly avoided running out of money, how they landed in the Winter 2019 Y Combinator cohort after a last-minute application, and how they’ve hired talent.

Connect with Nick & Board

https://www.board.live/

Connect with 1517 Fund

https://www.1517fund.com/take-action

Alex Schwarzkopf is the CEO and co-founder of Pillar Technologies, a company that prevents damages on construction sites by using sensors and predictive analytics.

Pillar’s sensors monitor temperature, dust particulates, noise, humidity, and more to prevent costly damages and identify mistakes sooner for construction firms.

In this conversation, Alex and 1517 Fund’s Zak Slayback discuss how Pillar got their first pilot test deal, why they pivoted from their initial product idea, and the importance of empathy in sales.

Connect with Alex & Pillar Technologies

https://pillar.tech/

Connect with 1517 Fund

https://www.1517fund.com/take-action

When 1517 Fund looks to invest in technology companies, one of our favorite questions is, “what’s to stop someone else from coming in and copying you?”

Pavle Jeremic had an incredibly exciting answer to that question. His firm, Aether Biomachines, is approaching control of 50% of all enzymatic data on Earth. In short order, they expect to reach 90%.

That means they’ll have a head start, and moat, on applying machine learning and neural networks to high potential information.

Pavle envisions this fundamentally changing the future of biological manufacturing for chemicals, food, and more.

He discusses all this with 1517 Fund’s Zak Slayback in this 50-minute conversation.

Connect with Pavle & Aether Biomachines

aetherbio.com

Connect with 1517 Fund

https://www.1517fund.com/take-action